Methylphenidate Sandoz Forðatafla 27 mg Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate sandoz forðatafla 27 mg

sandoz a/s - methylphenidatum hýdróklóríð - forðatafla - 27 mg

Methylphenidate Medical Valley Forðatafla 27 mg Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate medical valley forðatafla 27 mg

medical valley invest ab - methylphenidatum hýdróklóríð - forðatafla - 27 mg

Methylphenidate Medical Valley Forðatafla 18 mg Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate medical valley forðatafla 18 mg

medical valley invest ab - methylphenidatum hýdróklóríð - forðatafla - 18 mg

Methylphenidate Medical Valley Forðatafla 36 mg Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate medical valley forðatafla 36 mg

medical valley invest ab - methylphenidatum hýdróklóríð - forðatafla - 36 mg

Methylphenidate Sandoz Forðatafla 18 mg Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate sandoz forðatafla 18 mg

sandoz a/s* - methylphenidatum hýdróklóríð - forðatafla - 18 mg

Methylphenidate Sandoz Forðatafla 36 mg Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate sandoz forðatafla 36 mg

sandoz a/s* - methylphenidatum hýdróklóríð - forðatafla - 36 mg

Methylphenidate Medical Valley Forðatafla 54 mg Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate medical valley forðatafla 54 mg

medical valley invest ab - methylphenidatum hýdróklóríð - forðatafla - 54 mg

Dimethyl fumarate Neuraxpharm Euroopa Liit - islandi - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Mylan Euroopa Liit - islandi - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Euroopa Liit - islandi - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.